US Bancorp’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
US Bancorp's ATEX Position: Q2 2026 in Review
US Bancorp reduced its Anterix (ATEX) stake by 33% in Q2 2026, selling an estimated $4.4K and leaving 149 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3304.
US Bancorp first reported a position in ATEX in Q1 2020 and has held it in 25 quarters since. The position peaked at $19K in Q2 2022. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- US Bancorp held 149 shares of Anterix worth $15.3K as of Q2 2026.
- US Bancorp sold 75 Anterix shares in Q2 2026, an estimated $4.4K.
- Anterix made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3304 holding.
- US Bancorp first reported a position in Anterix in Q1 2020 and has held it in 25 quarters since.
- US Bancorp's Anterix position peaked at $19K in Q2 2022.
- 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.